Enhancing Recovery after Radical Prostatectomy
At Levee Medical, we are committed to designing solutions that aim to reduce complications associated with surgical treatment.
One in 8 men will develop prostate cancer*
Patients often choose surgery to treat prostate cancer
In most cases, surgery enables complete and immediate removal of cancer.
Urinary incontinence after prostatectomy remains a debilitating problem
It is the most feared complication following surgery for prostate cancer.
Return to daily life quicker and with confidence
Our goal is to minimize incontinence so that patients can turn the page after prostate cancer surgery.
Introducing
The first and only bioresorbable device to address urinary incontinence in radical prostatectomy patients
Focused on Recovery
Control and
Confidence
Simple and
Intuitive
Leadership Team
Bruce Choi
Founder & CTO
Adam Irving
CEO
Kevin Hopkins
Director of Quality
Dr. Michael Ferrandino
Medical Advisor
Gary McCord
Corporate Strategy Advisor
Sew-Wah Tay
Regulatory Advisor
Jesse Jones
General Counsel
Mike McKellar
Corporate Controller
Katie Arnold
Marketing Strategy Advisor
News
Levee Medical™ Announces the Closing of $6.6m Series A Financing
Company to Accelerate Development of Novel Urologic Device Designed to Improve Recovery Outcomes Post-Prostatectomy
Durham, NC – August 23, 2022 – Levee Medical, a medical device company designing solutions to improve surgical outcomes following prostate cancer, announced today it has closed an initial oversubscribed series A financing round, raising a total of $6.6 million. The funds will be used to advance product development, scale infrastructure, and expand the team to support the development of the company’s Voro™ Urologic Scaffold, a bioresorbable post-prostatectomy implant.